Phillip B. Maples
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Biotechnology top 2%
- Cancer Research and Treatments
Papers in
-
- RNA Interference and Gene Delivery 6
- Oncology 10
- CAR-T cell therapy research 4
- Co-authors
- John Nemunaitis (27 shared papers)Neil Senzer (20 shared papers)Beena O. Pappen (12 shared papers)David H. Kirn (2 shared papers)Britta Randlev (2 shared papers)Casey Cunningham (5 shared papers)Padmasini Kumar (9 shared papers)Shushan Rana (1 shared paper)
- Journals
- Cancer Gene Therapy (5 papers)Developmental Biology (3 papers)Molecular Therapy (3 papers)Journal of Clinical Oncology (2 papers)Gene Therapy (2 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Phillip B. Maples
37 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 94
- Oncology 1.1k
- Biotechnology 287
- Genetics 824
- Immunology 551
- Molecular Biology 1.0k
Countries citing papers authored by Phillip B. Maples
This map shows the geographic impact of Phillip B. Maples's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip B. Maples with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip B. Maples more than expected).
Fields of papers citing papers by Phillip B. Maples
This network shows the impact of papers produced by Phillip B. Maples. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip B. Maples. The network helps show where Phillip B. Maples may publish in the future.
Co-authors
The 25 scholars most cited alongside Phillip B. Maples, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B-55kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. | 2000 | 331 |
| 2 | 2006 | 286 | |
| 3 | 2001 | 228 | |
| 4 | 2009 | 207 | |
| 5 | 2004 | 183 | |
| 6 | 2008 | 132 | |
| 7 | 2009 | 116 | |
| 8 | 2008 | 72 | |
| 9 | 2007 | 65 | |
| 10 | Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. | 1993 | 54 |
| 11 | 2000 | 48 | |
| 12 | 2011 | 44 | |
| 13 | 2014 | 41 | |
| 14 | 2009 | 41 | |
| 15 | 2011 | 37 | |
| 16 | 2010 | 36 | |
| 17 | 1998 | 30 | |
| 18 | 1981 | 28 | |
| 19 | 2010 | 24 | |
| 20 | 2010 | 20 |
About Phillip B. Maples
Phillip B. Maples is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Biotechnology, having authored 37 papers that have together received 2.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Research and Treatments (8 papers), Inflammatory Myopathies and Dermatomyositis (6 papers), RNA Interference and Gene Delivery (6 papers), Hemoglobinopathies and Related Disorders (5 papers), Erythrocyte Function and Pathophysiology (5 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Oncology (1.1k citations), Biotechnology (287 citations), Genetics (824 citations), Immunology (551 citations) and Molecular Biology (1.0k citations). Phillip B. Maples has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include John Nemunaitis, Neil Senzer, Beena O. Pappen, David H. Kirn, Britta Randlev, Casey Cunningham, Padmasini Kumar, Shushan Rana, Alex Tong and Michael Nemunaitis. Their work appears in journals such as Cancer Gene Therapy, Developmental Biology, Molecular Therapy, Journal of Clinical Oncology and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.